Atlas Trials

Zambon SpA

23 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Zambon SpA

RecordFirmDate
A Retrospective Chart Review Study of Patients With Chronic Lung Allograft Dysfunction-Bronchiolitis Obliterans Syndrome (CLAD-BOS) Post Lung Transplantation (NCT06503770)Zambon SpA2024-06-27
A Single and Multiple Dose Study to Assess How the Drug Enters, Moves Through and Exits the Body, Safety and Tolerability of Safinamide in Healthy Adult Chinese Volunteers (NCT03887221)Zambon SpA2021-06-21
Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3) (NCT04039347)Zambon SpA2020-03-12
A Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis After Hematopoietic Transplant (BOSTON-4) (NCT04107675)Zambon SpA2020-02-11
An Observational Study on Safinamide, Rasagiline and Other Standard of Care in PD (NCT03994328)Zambon SpA2019-12-03
A Study to Evaluate Pharmacokinetics, Safety and Tolerability of Single and Multiple Intravenous Doses of N-acetylcysteine (NAC) in Chinese Healthy Volunteers (NCT03881163)Zambon SpA2019-11-11
Safinamide for Multiple System Atrophy (MSA) (NCT03753763)Zambon SpA2019-10-29
Safinamide for Levodopa-induced Dyskinesia (PD-LID) (NCT03987750)Zambon SpA2019-10-01
A Study to Evaluate the Efficacy and Safety of Safinamide, as add-on Therapy, in Idiopathic Chinese Parkinson's Disease (PD) Patients With Motor Fluctuations Treated With Stable Doses of Levodopa (NCT03881371)Zambon SpA2019-08-01
A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions (NCT03843541)Zambon SpA2019-06-25
Effect of Safinamide on Parkinson's Disease Related Chronic Pain (NCT03841604)Zambon SpA2019-04-09
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2) (NCT03656926)Zambon SpA2019-03-26
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1) (NCT03657342)Zambon SpA2019-03-26
Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium. (NCT03460704)Zambon SpA2018-01-29

Track Zambon SpA automatically

Every clearance here is in the API, with alerts when new ones post.